作为癌症治疗点的CARM1阿金氨基甲基转移酶
Margarida Santos1, Jee Won Hwang1, Mark T Bedford1
1Department of Epigenetics & Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
The Journal of biological chemistry
|August 3, 2023
概括
同活性剂相关的阿尔金因甲基转移酶1 (CARM1) 是一种在许多癌症中过度表达的酶. 向CARM1可能通过破坏瘤转录因子通路,为癌症提供耐受性良好的治疗策略.
科学领域:
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
背景情况:
- 同活性剂相关的阿尔金因甲基转移酶1 (CARM1) 是一种酶,它修改了参与RNA生产和加工的蛋白质.
- CARM1基质包括基因子,转录因子和拼接因子,在基因调节中发挥作用.
- 在许多癌症类型中观察到过度表达CARM1,这有助于转录因子成.
研究的目的:
- 根据小鼠研究,审查CARM1的体内功能.
- 详细阐述CARM1.1调节的转录通路.
- 突出最近关于CARM1致癌性质及其治疗潜力的发现.
主要方法:
- 关于CARM1活体功能研究的文献综述,特别是在小鼠模型中.
- 对确定CARM1在转录调节中的作用的研究进行分析.
- 综合了最近的发现,将CARM1与瘤发生联系起来.
主要成果:
- 在RNA生产,加工和表观遗传调节中,CARM1起作用.
- CARM1参与促进转录因子程序,驱动癌细胞转化.
- 与其他相关酶相比,CARM1淘汰对胚胎发育的危害较小,这表明潜在的治疗耐受性.
结论:
- 由于其在瘤性途径中的作用,CARM1是各种癌症的有希望的治疗标.
- 对CARM1抑制剂的进一步研究可能会导致新的癌症治疗方法.
- 向CARM1可能是解决癌症中转录因子成的可行策略.
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:23Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
02:34Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K